Comparison study of treatment given to children with asthma by a nurse practitioner, a general practitioner or a pediatrician. (Vergelijkende studie met betrekking tot de controle van kinderen met astma door de “nurse practitioner”, de huisarts of de kinderarts)

ISRCTN ISRCTN95392638
DOI https://doi.org/10.1186/ISRCTN95392638
Secondary identifying numbers N/A
Submission date
11/08/2011
Registration date
26/08/2011
Last edited
30/08/2011
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Respiratory
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Mr Maarten Kuethe
Scientific

Department of Pediatrics
Amphia hospital
PO Box 90157
Breda
4800 RL
Netherlands

Study information

Study designRandomized controlled trial
Primary study designObservational
Secondary study designRandomised controlled trial
Study setting(s)GP practice
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleComparison study to follow-up of treatment given to children with stable asthma by a nurse practitioner, a general practitioner or a pediatrician: a randomized controlled trial
Study acronymTRAM
Study objectivesTRAM (TRans mural Asthma Management). Treatment of children with stable asthma by a nurse practitioner is not inferior to treatment by a general practitioner or a pediatrician.
Ethics approval(s)TWOR Medical Centre "Rijnmond" South, Rotterdam approved on 11 January 2008, ref: nl.17972.101.07
Health condition(s) or problem(s) studiedPediatric asthma
InterventionChildren were randomly assigned to one of the three follow up arm and at baseline, one year & two year a variety of outcome measures were collected.

1. Management by general practitioner
2. Management by paediatrician
3. Management by asthma nurse
Intervention typeDrug
Pharmaceutical study type(s)
PhaseNot Applicable
Drug / device / biological / vaccine name(s)Inhaled corticosteroid (beta-2-agonist), PD20 methacholine
Primary outcome measure1. Airway hyper responsiveness
2. PD20 methacholine
Measured at baseline, one year & two year
Secondary outcome measures1. Forced expiratory volume in one second (FEV1) before and after bronchus dilatation with beta-2-agonist
2. Exhaled nitric oxide (NO)
3. Asthma Control Questionaire
4. Health economics
5. Prescribed medication
6. Quality of Care assessment by completing the QUOTE-CNSLD instrument by parents
7. Completion of Likert scale by the children
Overall study start date04/03/2005
Completion date28/01/2009

Eligibility

Participant type(s)Patient
Age groupChild
Lower age limit6 Years
Upper age limit16 Years
SexBoth
Target number of participants110
Key inclusion criteria1. Children 6-16 years
2. Moderate asthma as defined by the guideline of the dutch pediatric pulmonologists or diagnosed as asthma by their general practioner (GP) and on prophylactic treatment with inhaled corticosteroid (ICS)
Key exclusion criteriaSerious, poorly controlled asthma requiring step intravenous (IV) treatment according to the action plan in the guideline
Date of first enrolment04/03/2005
Date of final enrolment28/01/2009

Locations

Countries of recruitment

  • Netherlands

Study participating centre

Department of Pediatrics
Breda
4800 RL
Netherlands

Sponsor information

Amphia Hospital (Netherlands)
Hospital/treatment centre

Langendijk 75
Breda
4819 EV
Netherlands

Website http://www.amphia.nl/Pages/default.aspx
ROR logo "ROR" https://ror.org/01g21pa45

Funders

Funder type

Hospital/treatment centre

Amphia Hospital (Netherlands)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan